Tracking a new weapon against advanced prostate cancer in real patients

NCT ID NCT07093801

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how well a targeted radiation drug works for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. Researchers will follow 300 patients in real-world clinics for up to 18 months after treatment to see how long the cancer is controlled, if it improves survival, and how it affects quality of life and pain. The goal is to gather practical evidence on the drug's benefits and side effects outside of a controlled clinical trial.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Alessandria, AL, 15121, Italy
Novartis Investigative Site
RECRUITING

Asti, AT, 14100, Italy
Novartis Investigative Site
RECRUITING

Bergamo, BG, 24127, Italy
Novartis Investigative Site
RECRUITING

Brescia, BS, 25123, Italy
Novartis Investigative Site
RECRUITING

Catania, CT, 95123, Italy
Novartis Investigative Site
RECRUITING

Meldola, FC, 47014, Italy
Novartis Investigative Site
RECRUITING

Cona, FE, 44124, Italy
Novartis Investigative Site
RECRUITING

Foggia, FG, 71122, Italy
Novartis Investigative Site
RECRUITING

Florence, FI, 50134, Italy
Novartis Investigative Site
RECRUITING

Genova, GE, 16128, Italy
Novartis Investigative Site
RECRUITING

Genova, GE, 16132, Italy
Novartis Investigative Site
RECRUITING

Latina, LT, 04100, Italy
Novartis Investigative Site
RECRUITING

Macerata, MC, 62100, Italy
Novartis Investigative Site
RECRUITING

Milan, MI, 20133, Italy
Novartis Investigative Site
RECRUITING

Milan, MI, 20141, Italy
Novartis Investigative Site
RECRUITING

Milan, MI, 20162, Italy
Novartis Investigative Site
RECRUITING

Rozzano, MI, 20089, Italy
Novartis Investigative Site
RECRUITING

Palermo, PA, 90146, Italy
Novartis Investigative Site
RECRUITING

Perugia, PG, 06129, Italy
Novartis Investigative Site
RECRUITING

Pisa, PI, 56126, Italy
Novartis Investigative Site
RECRUITING

Aviano, PN, 33081, Italy
Novartis Investigative Site
RECRUITING

Rionero in Vulture, PZ, 85028, Italy
Novartis Investigative Site
RECRUITING

Reggio Emilia, RE, 42123, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00128, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00152, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00168, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00189, Italy
Novartis Investigative Site
RECRUITING

La Spezia, SP, 19121, Italy
Novartis Investigative Site
RECRUITING

Torino, TO, 10128, Italy
Novartis Investigative Site
RECRUITING

Mestre, VE, 30174, Italy
Novartis Investigative Site
RECRUITING

Negrar, VR, 37024, Italy
Novartis Investigative Site
RECRUITING

Naples, 80131, Italy

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION RESISTANT PROSTATE CANCER